Vaccine in combination with an immune checkpoint inhibitor for use in treating cancer

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11419927
APP PUB NO 20190247482A1
SERIAL NO

16306352

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A polypeptide for use in medicine is provided. The polypeptide is administered simultaneously, separately or sequentially with an immune checkpoint inhibitor. The polypeptide comprises at least one polypeptide comprising a region of at least 12 amino acids of a self-antigen or a sequence having at least 80% identity to the region. The polypeptide is less than 100 amino acids in length.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ULTIMOVACS ASAULLERNCHAUSSÉEN 64 OSLO 0379

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Gaudernack, Gustav Sandvika, NO 29 329
Tornes, Audun Drammen, NO 11 186

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Feb 23, 2026
7.5 Year Payment $3600.00 $1800.00 $900.00 Feb 23, 2030
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 23, 2034
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00